Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dropless vs. Less Drops Pharmaceutical Regimens After Cataract Surgery
NCT02819908Phase 4Completed
- Sponsor
- Eye Center of North Florida
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone, Moxisurge, vancomycin in post-operative inflammation, endophthalmitis, sponsored by Eye Center of North Florida. Started Sep 2015; status: completed.
02
Drugs
triamcinoloneMoxisurgevancomycin
03
Conditions
post-operative inflammationendophthalmitis
Beyond the preview
Go deeper on NCT02819908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819908.